Invention Grant
- Patent Title: Formulations of PBMCs
-
Application No.: US17563764Application Date: 2021-12-28
-
Publication No.: US12150982B2Publication Date: 2024-11-26
- Inventor: Howard Bernstein , Scott Loughhead , Matthew Booty , Kelan Hlavaty , Tarek Abdeljawad , Maisam Dadgar , Jason Murray , David Chirgwin , Harry An , Armon R. Sharei
- Applicant: STEMCELL TECHNOLOGIES CANADA INC.
- Applicant Address: CA Vancouver
- Assignee: STEMCELL TECHNOLOGIES CANADA INC.
- Current Assignee: STEMCELL TECHNOLOGIES CANADA INC.
- Current Assignee Address: CA Vancouver
- Agency: BERESKIN & PARR LLP/S.E.N.C.R.L., s.r.l.
- Agent Micheline Gravelle
- Main IPC: A61K39/12
- IPC: A61K39/12 ; A61K39/39 ; A61K47/20 ; A61K47/42 ; A61K39/00
Abstract:
The present application provides formulations of modified peripheral blood mononuclear cells (PBMCs), wherein the formulation comprises: PBMCs comprising at least one antigen (e.g., a human papillomavirus (HPV) antigen) and a cryopreservation medium. In some embodiments, the PBMCs are conditioned by incubating the PBMC in the presence of an adjuvant.
Public/Granted literature
- US20220241392A1 FORMULATIONS OF PBMCS Public/Granted day:2022-08-04
Information query
